Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118374146 | 11837414 | 6 | F | 2013 | 20160829 | 20151215 | 20160909 | EXP | CA-VALIDUS PHARMACEUTICALS LLC-CA-2015VAL000802 | VALIDUS | 0.00 | Y | 0.00000 | 20160909 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118374146 | 11837414 | 1 | PS | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | UNK | U | 17963 | ||||||||||
| 118374146 | 11837414 | 2 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG, QMO (EVERY 4 WEEKS); SANDOSTATIN LAR | Y | 0 | 30 | MG | |||||||
| 118374146 | 11837414 | 3 | SS | SANDOSTATIN | OCTREOTIDE ACETATE | 1 | Subcutaneous | UNK, (TEST DOSE) | 0 | ||||||||||
| 118374146 | 11837414 | 4 | SS | AFINITOR | EVEROLIMUS | 1 | Oral | 10 MG, QD | Y | 0 | 10 | MG | |||||||
| 118374146 | 11837414 | 5 | C | RAMIPRIL. | RAMIPRIL | 1 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118374146 | 11837414 | 1 | Hypertension |
| 118374146 | 11837414 | 2 | Pancreatic neuroendocrine tumour |
| 118374146 | 11837414 | 3 | Pancreatic neuroendocrine tumour |
| 118374146 | 11837414 | 4 | Product used for unknown indication |
| 118374146 | 11837414 | 5 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118374146 | 11837414 | HO |
| 118374146 | 11837414 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118374146 | 11837414 | Asthenia | |
| 118374146 | 11837414 | Blood pressure increased | |
| 118374146 | 11837414 | Cholelithiasis | |
| 118374146 | 11837414 | Cough | |
| 118374146 | 11837414 | Dizziness | |
| 118374146 | 11837414 | Hypersensitivity | |
| 118374146 | 11837414 | Jaundice | |
| 118374146 | 11837414 | Liver abscess | |
| 118374146 | 11837414 | Malaise | |
| 118374146 | 11837414 | Malignant neoplasm progression | |
| 118374146 | 11837414 | Neoplasm | |
| 118374146 | 11837414 | Ocular hyperaemia | |
| 118374146 | 11837414 | Pain | |
| 118374146 | 11837414 | Pneumonia | |
| 118374146 | 11837414 | Post procedural infection | |
| 118374146 | 11837414 | Pulmonary congestion | |
| 118374146 | 11837414 | Pyrexia | |
| 118374146 | 11837414 | Stomatitis | |
| 118374146 | 11837414 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118374146 | 11837414 | 2 | 20110506 | 0 | ||
| 118374146 | 11837414 | 3 | 20110329 | 20110329 | 0 | |
| 118374146 | 11837414 | 4 | 20150830 | 201509 | 0 |